.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Long-term outcomes are especially important when comparing surgery with conservative treatment for slowly progressive cervical spondylotic myelopathy. A ten-year prospective randomized study followed patients with mild-to-moderate disease and compared operative and conservative strategies. At the final assessment, no major difference was found in modified JOA score, patient-rated outcome or observed daily activities between groups. The findings reinforce the importance of selecting the right population when interpreting evidence against surgery. Patients with mild and stable disease may not derive the same urgent benefit as patients with progressive neurological impairment. For HCPs, the practical lesson is to monitor trajectory carefully. Worsening gait, dexterity, weakness or objective myelopathy can change the treatment threshold even when symptoms initially appear mild. The paper also reminds clinicians that long-term functional outcomes can remain stable in some carefully selected patients managed without surgery. Shared decision-making should therefore incorporate neurological severity, rate of progression, imaging findings, patient preference and surgical risk rather than assuming that all cord compression requires immediate operative treatment.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Long-term outcomes are especially important when comparing surgery with conservative treatment for slowly progressive cervical spondylotic myelopathy. A ten-year prospective randomized study followed patients with mild-to-moderate disease and compared operative and conservative strategies. At the final assessment, no major difference was found in modified JOA score, patient-rated outcome or observed daily activities between groups. The findings reinforce the importance of selecting the right population when interpreting evidence against surgery. Patients with mild and stable disease may not derive the same urgent benefit as patients with progressive neurological impairment. For HCPs, the practical lesson is to monitor trajectory carefully. Worsening gait, dexterity, weakness or objective myelopathy can change the treatment threshold even when symptoms initially appear mild. The paper also reminds clinicians that long-term functional outcomes can remain stable in some carefully selected patients managed without surgery. Shared decision-making should therefore incorporate neurological severity, rate of progression, imaging findings, patient preference and surgical risk rather than assuming that all cord compression requires immediate operative treatment.
4 weeks back
Discover how catalytic nanozymes redefine autoimmune disease therapy by establishing a physiological redox set-point to restore immune tolerance without broad immunosuppression.
Last week
Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
3 weeks back
A landmark comparative study evaluates atrial electrophysiology across humans, swine, and rodents. By linking cellular recordings with transcriptomics and in silico modeling, researchers resolve cross-species gaps, explaining translational failures to advance targeted therapies for atrial arrhythmias.
3 weeks back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
last month
Researchers have developed an innovative ultrasound-responsive nano-contrast agent that co-delivers CIITA-siRNA and rapamycin directly to inflamed thyroid tissue, significantly reducing autoimmune injury and thyroid autoantibodies in preclinical models of Hashimoto thyroiditis.
3 weeks back
